Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine
JDD authors Mihir Shah MD, Jenna Wald MD, and C. William Hanke MD MPH present a case of a patient with eruptive squamous cell carcinomas following treatment with Fludarabine to highlight not only the risk of cSCC in CLL patients and the increased risk for atypical cutaneous malignancies after treatment with systemic therapies such as fludarabine, but also to discuss treatment options for this …
JDD authors Mihir Shah MD, Jenna Wald MD, and C. William Hanke MD MPH present a case of a patient with eruptive squamous cell carcinomas following treatment with Fludarabine to highlight not only the risk of cSCC in CLL patients and the increased risk for atypical cutaneous malignancies after treatment with systemic therapies such as fludarabine, but also to discuss treatment options for this … Continue reading "Eruptive Squamous Cell Carcinomas Following Treatment With Fludarabine"
The use of antimicrobial therapy in the field of cutaneous surgery can be a difficult and controversial topic. Overall, there are a lack of randomized controlled clinical trials evaluating the efficacy of antimicrobial prophylaxis within our field. As a result, much of the recommendations for antimicrobial prophylaxis are extrapolated from other fields, such as dentistry, cardiology, and orthopedi … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic & Surgical Conference, interviewed Dr. George Han, associate professor of dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Watch as Dr. Han shares his tips for breaking into the conference circuit. Learn why it’s important to find your niche and the right mentor. Hear which meeting Dr. H … 
These lesions can occur with which of the following?
A. Morphea
B. Leprosy
C. Erythema nodosum
D. Sarcoid
E. Pregnancy
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
… 
Increased expression of which of the following is most associated with the patient’s condition?
A. Interferon-gamma
B. Interleukin-2
C. Interleukin-13
D. Transforming growth factor-beta
E. Tumor necrosis factor-alpha
To find out the correct answer and read the explanation, click here.
Brought to you by our brand partner
…